The differences in the number of ChIP-seq peaks (Fig. 5A) and in genomic distribution of DNA binding sites (Fig. 5B) between IDH-WT and IDH-MUT suggest a stronger transcriptional regulation by REST (including both repression and activation) in IDH-WT glioma cells. The gene discussed is IDH2; the disease is central nervous system cancer.